arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1801.06227math.OCq-bio.QM
收藏

控制HIV感染患者的IL-7注射

Controlling IL-7 injections in HIV-infected patients

Chloé Pasin, François Dufour, Laura Villain, Huilong Zhang, Rodolphe Thiébaut

摘要:

包括重复注射的免疫干预被广泛使用,因为它们被认为可以提高免疫应答的数量和质量。然而,他们也提出了几个仍然没有答案的问题,特别是注射的数量或不同注射之间的延迟,以实现这一目标。实际和财政方面的考虑给这些问题增加了限制,特别是在人类研究的框架内。我们在这里特别关注使用白细胞介素-7(IL-7)注射在艾滋病毒感染患者的抗逆转录病毒治疗,但仍然无法恢复正常水平的CD 4 + T淋巴细胞。临床试验已经表明,反复注射IL-7可以通过影响CD 4 + T细胞的增殖和存活,帮助维持CD 4 + T淋巴细胞水平超过每微升500个细胞的限度。然后,我们的目的是回答这个问题:如何保持患者的CD 4 + T淋巴细胞的水平,通过使用最少的注射次数(即优化注射策略)?基于先前开发的CD 4 + T淋巴细胞在这种情况下的动力学机制模型,我们通过分段确定性马尔可夫模型来模拟该过程。然后,我们解决这个问题,通过使用一些最近建立的理论脉冲控制问题,以开发一个数值工具,确定最优策略。作为概念的证明,在降阶模型上获得结果:该方法允许为给定患者定义最优策略。该方法可应用于临床试验中注射方案的优化。

英文摘要:

Immune interventions consisting in repeated injection are broadly used as they are thought to improve the quantity and the quality of the immune response. However, they also raised several questions that remains unanswered, in particular the number of injections to make or the delay to respect between different injections to acheive this goal. Practical and financial considerations add constraints to these questions, especially in the framework of human studies. We specifically focus here on the use of interleukine-7 (IL-7) injections in HIV-infected patients under antiretroviral treatment, but still unable to restore normal levels of CD4+ T lymphocytes. Clinical trials have already shown that repeated cycles of injections of IL-7 could help maintaining CD4+ T lymphocytes levels over the limit of 500 cells per microL, by affecting proliferation and survival of CD4+ T cells. We then aim at answering the question : how to maintain a patient's level of CD4+ T lymphocytes by using a minimum number of injections (ie optimizing the strategy of injections) ? Based on mechanistic models that were previously developed for the dynamics of CD4+ T lymphocytes in this context, we model the process by a piecewise deterministic Markov model. We then address the question by using some recently established theory on impulse control problem in order to develop a numerical tool determining the optimal strategy. Results are obtained on a reduced model, as a proof of concept : the method allows to defined an optimal strategy for a given patient. This method could applied to optimize injections schedules in clinical trials.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑